CLIR Q1 2026 Earnings EPS Misses Estimates as Company Navigates Development Stage GeneDx Holdings Q1 2026 Earnings Significant EPS Miss Shares Decline ESPR Q1 2026 Earnings A BottomLine Miss as Investors Look for Growth Catalysts Sangoma Technologies Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter VTVT Q1 2026 Earnings Massive EPS Surprise Driven by a NonRecurring Gain Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development